ENVISTA HOLDINGS CORPORATION (NVST) Operating Margin
- Operating margin · 12 months: Value 9.58%; Formula and calculation Operating income / revenue. Period ending 2026-07-03..
Operating margin
Overview →Financial period ending 2026-07-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 9.58% | Operating income / revenue. Period ending 2026-07-03. $273.60M ÷ $2.86B × 100 ≈ 9.58% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 273.60M USD | Operating Income (Loss) |
| Revenue | 2.86B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.28B USD | Cost of Goods and Services Sold |
| Research and development | 120.80M USD | Research and Development Expense |
| Selling, general and administration | 1.18B USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-07-03 | $273.60M | $2.86B | $1.28B | $120.80M | $1.18B | 9.58% |
| 2026-04-03 | $239.60M | $2.81B | $1.27B | $118.70M | $1.18B | 8.53% |
| 2025-12-31 | $216.10M | $2.72B | $1.23B | $114.00M | $1.16B | 7.95% |
| 2025-09-26 | $188.90M | $2.62B | $1.17B | $108.60M | $1.15B | 7.20% |
| 2025-06-27 | $152.30M | $2.55B | $1.16B | $105.80M | $1.14B | 5.97% |
| 2025-03-28 | $-1.05B | $2.50B | $1.15B | $101.10M | $1.14B | -41.83% |
| 2024-12-31 | $-1.04B | $2.51B | $1.14B | $99.10M | $1.16B | -41.35% |
| 2024-09-27 | $-1.29B | $2.50B | $1.17B | $92.60M | $1.12B | -51.42% |
| 2024-06-28 | $-1.22B | $2.53B | $1.15B | $89.40M | $1.11B | -48.34% |
| 2024-03-29 | $7.50M | $2.56B | $1.13B | $92.60M | $1.08B | 0.29% |
| 2023-12-31 | $31.50M | $2.57B | $1.13B | $93.80M | $1.06B | 1.23% |
| 2023-09-29 | $322.30M | $2.58B | $1.11B | $98.20M | $1.05B | 12.48% |
| 2023-06-30 | $313.50M | $2.58B | $1.11B | $101.90M | $1.06B | 12.14% |
| 2023-03-31 | $299.80M | $2.56B | $1.10B | $100.20M | $1.06B | 11.69% |
| 2022-12-31 | $319.20M | $2.57B | $1.09B | $100.10M | $1.06B | 12.42% |
| 2022-09-30 | $277.30M | $2.56B | $1.11B | $100.30M | $1.07B | 10.83% |
| 2022-07-01 | $284.50M | $2.54B | $1.09B | $98.30M | $1.06B | 11.22% |
| 2022-04-01 | $302.60M | $2.53B | $1.09B | $99.10M | $1.04B | 11.97% |
| 2021-12-31 | $306.20M | $2.51B | $1.08B | $100.50M | $1.02B | 12.20% |
| 2021-10-01 | $323.40M | $2.83B | $1.30B | $113.00M | $1.09B | 11.44% |
| 2021-07-02 | $373.00M | $2.82B | $1.28B | $110.00M | $1.06B | 13.22% |
| 2021-04-02 | $166.60M | $2.44B | $1.17B | $96.20M | $1.01B | 6.82% |
| 2020-12-31 | $33.30M | $2.28B | $1.12B | $100.80M | $1.02B | 1.46% |
| 2020-10-02 | $14.50M | $2.27B | $1.11B | $109.10M | $1.04B | 0.64% |
| 2020-07-03 | $23.80M | $2.29B | $1.10B | $122.90M | $1.04B | 1.04% |
| 2020-04-03 | $207.60M | $2.64B | $1.21B | $146.10M | $1.07B | 7.87% |
| 2019-12-31 | $277.50M | $2.75B | $1.24B | $154.70M | $1.08B | 10.09% |
| 2019-09-27 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-28 | (m) | $2.81B | (m) | (m) | (m) | (m) |
| 2019-03-29 | (m) | $2.83B | (m) | (m) | (m) | (m) |
| 2018-12-31 | $298.40M | $2.84B | $1.24B | $172.00M | $1.13B | 10.49% |
| 2018-09-28 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-29 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $386.60M | $2.81B | $1.19B | $172.40M | $1.06B | 13.75% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DENTSPLY SIRONA Inc. (XRAY) | United States | $1.900B | -3.87 |